When Evelyn H. Lauder founded the Breast Cancer Research Fund, her mission was clear: to search out a cure for breast cancer. The progress that has been made within the last 30 years is extraordinary, with BCRF-funded researchers liable for major breakthroughs within the prevention, treatment and cure of the disease. Since BCRF’s inception in 1993, there was a 43 percent decline in deaths as a consequence of breast cancer, and greater than 4 million survivors of the disease.

The Estée Lauder Cos.’ Breast Cancer Campaign, which is marking its thirtieth anniversary this yr, has been a significant funder of BCRF, raising greater than $100 million for research. In late October, BCRF honored the company with the Sandra Taub Humanitarian Award at its 2022 Symposium and Awards Luncheon, raising one other $3.5 million for the cause.

“I’m humbled to be on this room amongst the brainiest scientists on the earth and probably the most generous supporters,” said Elizabeth Hurley, who was available to present the respect to Lauder chief executive officer Fabrizio Freda. “Thirty years ago, there was little or no breast cancer awareness and funding, and Evelyn advanced. She was a tireless, fabulous woman who devoted her life to saving other women’s lives.”

Accepting the award, Freda first thanked Leonard A. Lauder, William P. Lauder and your entire family for his or her tireless commitment. “We imagine our company’s success is deeply rooted in living our values, and people values have at all times included supporting outstanding organizations like BCRF,” he said. “We’re so proud that the Breast Cancer Campaign has turn into a cornerstone of our social investments in women’s advancement and health and we’re so grateful for all who’ve supported it.”

William Lauder, who was co-chair of the event with Kinga Lampert, noted the widespread impact of BCRF’s work. “Breast cancer effects everyone — all ages, race, nationality,” he said. “BCRF is exclusive in its role as a world convener. We support 255 scientists from all over the world who’re capable of network with their peers without having to compete for funding.”

The Jill Rose Award for Scientific Excellence was presented to Maria Jasin, Ph.D., whose mother died of the disease when Jasin was only nine years old. Today, her work has been instrumental in understanding the BCRA1 and BRCA2 genes.

Freda noted that despite the advances made, there’s more that “can and shall be done,” citing the corporate’s pledge to donate $15 million over the subsequent five years to research the health comorbidities and the biology of breast cancer in Black women, who see 41 percent higher mortality rates than white women.

“We’re honored to partner with BCRF to secure Evelyn Lauder’s vision to finish breast cancer,” he said. “As Evelyn said, it could never be done by one person. It must be done by a gaggle and you might be this group.”